FAKTOR RISIKO UNTUK TINGKAT KEPARAHAN COVID-19: ANALISIS META

Authors

  • Fibia Sentauri Cahyaningrum Institut Teknologi dan Bisnis Ahmad Dahlan Lamongan
  • Isna Ayu Safitri Kusuma Dewi Institut Teknologi dan Bisnis Ahmad Dahlan Lamongan

DOI:

https://doi.org/10.69916/jkbti.v2i1.26

Keywords:

Comorbidities, COVID-19, fixed effect, odds ratio, symptom

Abstract

Novel coronavirus adalah virus jenis baru yang menyebabkan COVID-19 di mana penyakit ini dapat memberikan dampak yang fatal kepada penderitanya. Empat studi mengenai COVID-19 telah dilakukan analisis meta mengenai faktor risiko gejala dyspnea, batuk, demam, diare, riwayat diabetes, hipertensi, Chronic Obstructive Pulmonary Disease (COPD), gangguan fungsi hati, dan Cardio Vascular Disease (CVD) terhadap tingkat keparahan COVID-19. Hasil analisis meta untuk faktor risiko yang signifikan antara lain: dyspnea (OR=3.53, 95% CI: 2.62-4.75), diare (OR=1.73, 95% CI: 1.03-2.89), riwayat penyakit diabetes (OR=2.65, 95% CI: 1.77-3.98), hipertensi (OR=2.25, 95% CI: 1.64-3.08), COPD (OR=6.26, 95% CI: 2.47-15.87), dan CVD (OR=2.84, 95% CI: 1.64-4.90). Faktor risiko gejala batuk, gejala demam, dan riwayat gangguan fungsi hati tidak berhubungan dengan tingkat keparahan COVID-19.

Downloads

Download data is not yet available.

Author Biographies

Fibia Sentauri Cahyaningrum, Institut Teknologi dan Bisnis Ahmad Dahlan Lamongan

 

 

Isna Ayu Safitri Kusuma Dewi, Institut Teknologi dan Bisnis Ahmad Dahlan Lamongan

 

 

 

References

World Health Organization, “Coronavirus disease (COVID-19).” https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed Jan. 14, 2023).

W. Guan et al., “Clinical Characteristics of Coronavirus Disease 2019 in China,” N. Engl. J. Med., vol. 382, no. 18, pp. 1708–1720, Apr. 2020, doi: 10.1056/NEJMOA2002032/SUPPL_FILE/NEJMOA2002032_DISCLOSURES.PDF.

C. Andrade, “Understanding relative risk, odds ratio, and related terms: as simple as it can get,” J. Clin. Psychiatry, vol. 76, no. 7, pp. e857–e861, Jul. 2015, doi: 10.4088/JCP.15F10150.

M. Borenstein, L. V. Hedges, J. P. T. Higgins, and H. R. Rothstein, “Introduction to meta-analysis,” Introd. to Meta-Analysis, pp. 1–421, Jan. 2009, doi: 10.1002/9780470743386.

M. W. Fagerland, “Evidence-Based Medicine and Systematic Reviews,” Res. Med. Biol. Sci. From Plan. Prep. to Grant Appl. Publ., pp. 431–461, Jun. 2015, doi: 10.1016/B978-0-12-799943-2.00012-4.

J. jin Zhang et al., “Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China,” Allergy, vol. 75, no. 7, pp. 1730–1741, Jul. 2020, doi: 10.1111/ALL.14238.

C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” Lancet, vol. 395, no. 10223, pp. 497–506, Feb. 2020, doi: 10.1016/S0140-6736(20)30183-5.

D. Wang et al., “Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China,” JAMA, vol. 323, no. 11, pp. 1061–1069, Mar. 2020, doi: 10.1001/JAMA.2020.1585.

Downloads

Published

2023-01-20

PlumX Metrics

Scite Metrics

Altmetric

How to Cite

[1]
F. Sentauri Cahyaningrum and I. Ayu Safitri Kusuma Dewi, “FAKTOR RISIKO UNTUK TINGKAT KEPARAHAN COVID-19: ANALISIS META”, JKBTI, vol. 2, no. 1, pp. 43–53, Jan. 2023.

Issue

Vol. 2 No. 1 (2023): January 2023

Section

Articles

License

Copyright (c) 2023 Fibia Sentauri Cahyaningrum, Isna Ayu Safitri Kusuma Dewi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC